Using GLP1 receptor agonists to treat cardiac patients with diabetes
HTML-код
- Опубликовано: 7 сен 2024
- At our 2018 symposium, "Management of Type 2 Diabetes in Patients with CVD: Focus on Heart Failure," Sunnybrook's Dr. Julie Lovshin explores GLP1 receptor agonist therapy in the setting of type 2 diabetes.
how much would glp 1 reduce blood sugar levels taken alone